今日の臨床サポート 今日の臨床サポート
関連論文:
img  7:  Murakami S, Özgüroğlu M, Villegas A, et al. PACIFIC: A double-blind, placebo-controlled Phase III study of durvalumab as consolidation therapy after chemoradiation in patients with locally advanced, unresectable NSCLC(ESMO Asia 2017 Congress, 403O). Ann oncol 2017; 28(suppl_10) mdx670.

放射線肺障害

戻る